Cytek Biosciences closes Series C round
Fremont, California-based Cytek Biosciences Inc, a provider of flow cytometry solutions, has raised an undisclosed amount of Series C funding. Northern Light Venture Capital and 3E Bioventures led the round. In conjunction with the funding, Feng Deng, founder of Northern Lights Ventures, will join Cytek’s board of directors.
25 September 2018•1 min read
